EU Eudamed database for medical devices: La Sagrada Familia or Chartes cathedral?

Schermafbeelding 2014-01-24 om 00.20.37I had the pleasure of presenting at the Informa Conference on the Medical Devices Directives and the Revision in Brussels today. An nice conference with a good overview of what is coming our way in terms of EU medical devices regulation 2.0 – or not.

Everything to everyone

My subject was the Eudamed database under the revision project – in other words what functions the currently existing Eudamed database will have under the new medical devices regulation (and I haven’t even looked at the IVD regulation, but it’s functions will be largely similar under that regulation so this presentation gives you a good mutatis mutandis overview for IVDs – even for the clinical part as IVDs will be subject to clinical investigation of their own (interventional clinical performance studies).

Eudamed

Source: Jacques Thielen (Medtronic) Informa Post Market Surveillance and Vigilance Conference Berlin February 2013

The Commission has clearly envisaged that the Eudamed database that provokes many a swear word in a multitude of languages from its current users because of its dubious speed and less than stellar usability, just to mention a few points, will become everything to everyone in its 3.0 version. The four existing pillars of the current Eudamed cathedral (as it is starting to be called) will be updated and two more will be added.

The Parliament threw in access to the database for basically everyone, as well as mandatory user friendly interface and a 7th pillar that is not in this picture for (special) notified bodies and certificates.

More in detail

There is a lot more to it, which you can see in my below presentation at the conference:

[slideshare id=30575311&style=border: 1px solid #CCC; border-width: 1px 1px 0; margin-bottom: 5px; max-width: 100%;&sc=no]

But: will it be ever be built?

The question now is: will the Commission pull this off? I have heard very cynical remarks both off and on the record about this, and certainly made some of my own, given the speed with which Eudamed was developed so far and given what it currently offers. So we’ll have to see what kind of cathedral it will be: the Chartes cathedral (a very nice one indeed and impressively built in 25 years) or the Sagrada Familia in Barcelona, a flamboyant hodgepodge of design from different eras but mainly under Gaudi influence, under construction since 1885 and currently (if donations allow) planned to be finished in the first 1/3 of the 21th century, give or take a few years. Of course, it can always be worse: in the end the Cologne cathedral took 600 years to complete, but let’s start optimistically. Everybody knows that very complex and highly political IT projects never suffer delays.

Another option is that the cathedral does not even get built any time soon, or not in this design, because it is becoming more and more likely by the week that the Greek presidency will not complete the revision dossier before the elections. And we’ll only have to see what Eudamed 3.0 will look like when the regulations get back into the legislative process in some shape or form after the elections.


Navigate through our knowledgebase

Related articles

Article

Bottleneck of bottlenecks for notified body capacity

People that are downplaying the notified body bottleneck may need to start to revisit their position with notified body LRQA now also dropping out of the notified body pool for medical devices…

Read more

Article

Vanilla custard or custard with vanilla taste?

In a recent decision of the Board of Appeal of the Dutch Advertising Code Committee (ACC), it was made clear that providing food information to consumers is serious business. The ACC in the Netherlands is a self-regulatory body, comparable to the Advertising Standards Authority in the UK and the German Advertising Standards Council (“Deutscher Werberat”)  […]

Article

Trends at Vitafoods … and what you should know if you decide to be part of it

From 7 – 9 May 2019, the Vitafoods conference took place again in Geneva. For a few years in a row, I presented at the Education Program. This year I was asked to discuss the application of CBD in food products, which is currently a hot topic. Below, I will share the insight from my […]